Life Sciences 2004 "Trends, Funding and Other Challenges"

Thursday, April 22, 2004
Time: 06:00 PM
Add to Calendar
Thursday April 22, 2004 • 6:00PM to 8:30PM
IBMS Networking & Educational Event at the Stanford Faculty Club


The Life Science Industry continues to be a strong robust sector for investment, business and technology professionals. 2003 was the year Life Science awoke from its slumber. IPO activity increased significantly from previous years. According to the National Venture Capital Association, 2003 investments in US medical device and biotechnology companies were $1.5 billion and $3.3 billion respectively.

2004 continues the investment trend. Life Science companies are riding the wave and are seeking IPOs and acquisition opportunities. Recent activities such as the sale of Novacept to Cytyc, and completion of Anadys Pharmaceuticals initial public offering are examples of a growing investment trend.

Our speaker panel of founder, executive management, and venture capitalist will give us their perspective on 2004 funding trends and growth challenges.
Patrick Enright
General Partner
Pequot Ventures
Pequot Capital Management, Inc.

Patrick Lynn
CEO & Founder
Concentus Medical

Thomas A. Schreck
Co-Founder & CFO
Durect Corporation

Reviewed/approved by talieshah -.


iphone5ケース: iphone4ケース: iphone4Sケース: iphoneカバー: iPhoneケース: iPHONE4ケース: iphone4S ケース: iphone4レザーケース: iphone4 革ケース: iphone4 ハードケース: iPhone4ポール フランクケース: iPhone4 Paul Frank:

Posted by: iphone4 ハードケース at 2013-03-08 19:24:41

Leave a Reply

Remember personal info?

About 7rooz
7rooz Services
Other Stuff
Copyright © 2002-2024